Bayer AG To Discuss Update on Five-Point Plan To Address Potential Future Roundup Litigation Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor Conference Call on July 29, 2021. (Operator Instructions)
I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead.
Thank you very much, Emma. Good afternoon, and thanks for joining us today. I would like to welcome all of you to today's Glyphosate Litigation Update Call. We really appreciate everyone participating today as we are absolutely aware that today is a very busy reporting day.
With me on the call today is Werner Baumann, our CEO; and he will be joined in the Q&A session by Wolfgang Nickl, our CFO; Bill Dodero, our Head of Litigation; and Liam Condon, CEO for the Crop Science division.
If we have some time at the end today, we might also be able to cover just a bit the PCB as there were some -- was a reverse jury verdict 2 days ago, which I think would be of interest for some of you to get a statement on this one, too, but let's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |